Flora López-López

510 total citations
8 papers, 111 citations indexed

About

Flora López-López is a scholar working on Oncology, Infectious Diseases and Neurology. According to data from OpenAlex, Flora López-López has authored 8 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Infectious Diseases and 2 papers in Neurology. Recurrent topics in Flora López-López's work include COVID-19 Clinical Research Studies (2 papers), COVID-19 and healthcare impacts (2 papers) and Intracranial Aneurysms: Treatment and Complications (1 paper). Flora López-López is often cited by papers focused on COVID-19 Clinical Research Studies (2 papers), COVID-19 and healthcare impacts (2 papers) and Intracranial Aneurysms: Treatment and Complications (1 paper). Flora López-López collaborates with scholars based in Spain, Netherlands and Poland. Flora López-López's co-authors include Ramón Yarza, Carlos Lumbreras, María Dolores Folgueira, Luis Paz‐Ares, D. Paredes, Carmen Díaz‐Pedroche, Javier Baena, Carlos Gómez-Martín, Kirsten Utpatel and Frederik J.H. Hoogwater and has published in prestigious journals such as European Journal of Cancer, Cancers and Journal of Thrombosis and Thrombolysis.

In The Last Decade

Flora López-López

7 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flora López-López Spain 5 76 47 24 20 13 8 111
Jianhua Chi China 5 33 0.4× 50 1.1× 9 0.4× 16 0.8× 22 1.7× 12 183
Abinet M. Aklilu United States 6 30 0.4× 75 1.6× 14 0.6× 35 1.8× 45 3.5× 15 190
Tian Yang China 8 29 0.4× 37 0.8× 15 0.6× 19 0.9× 18 1.4× 28 179
Ismail Kalla South Africa 7 33 0.4× 50 1.1× 37 1.5× 11 0.6× 16 1.2× 25 152
Tanya Singh Kakar United States 5 40 0.5× 18 0.4× 20 0.8× 19 0.9× 8 0.6× 9 140
A Scorza Italy 3 112 1.5× 21 0.4× 26 1.1× 35 1.8× 11 0.8× 3 176
Javier Rodriguez United States 5 34 0.4× 45 1.0× 16 0.7× 16 0.8× 7 0.5× 15 118
Cindy Pynadath United States 7 26 0.3× 86 1.8× 36 1.5× 24 1.2× 30 2.3× 11 176
Christopher Harlow United Kingdom 5 34 0.4× 49 1.0× 21 0.9× 21 1.1× 14 1.1× 9 107
Lauren A. Decker United States 5 42 0.6× 60 1.3× 10 0.4× 11 0.6× 27 2.1× 6 125

Countries citing papers authored by Flora López-López

Since Specialization
Citations

This map shows the geographic impact of Flora López-López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora López-López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora López-López more than expected).

Fields of papers citing papers by Flora López-López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora López-López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora López-López. The network helps show where Flora López-López may publish in the future.

Co-authorship network of co-authors of Flora López-López

This figure shows the co-authorship network connecting the top 25 collaborators of Flora López-López. A scholar is included among the top collaborators of Flora López-López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora López-López. Flora López-López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Paredes, D., et al.. (2023). Reactivación de citomegalovirus en pacientes con gastritis inmunomediada. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(5). 298–300. 1 indexed citations
2.
Nooijen, Lynn E., Jesús M. Bañales, Marieke T. de Boer, et al.. (2022). Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers. 14(10). 2389–2389. 16 indexed citations
3.
Paredes, D., Covadonga Gómez‐Cuervo, Carlos Gómez-Martín, et al.. (2021). Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid. Journal of Thrombosis and Thrombolysis. 53(2). 471–478. 6 indexed citations
4.
García‐Alfonso, Pilar, Fabienne Thomas, Sara López‐Tarruella, et al.. (2021). DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach. Journal of Personalized Medicine. 11(8). 792–792. 5 indexed citations
5.
Yarza, Ramón, D. Paredes, Flora López-López, et al.. (2020). SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death. European Journal of Cancer. 135. 242–250. 69 indexed citations
6.
Vivancos, J, et al.. (1998). Registro de urgencias neurológicas en un hospital de tercer nivel. Revista de Neurología. 27(159). 750–750. 11 indexed citations
7.
Fernandez-García, Cristina, et al.. (1998). [What sort of stroke requires patient admittance to the hospital? Factors for deciding on hospitalization].. PubMed. 27(158). 662–6. 3 indexed citations
8.
Segura, Tomás, et al.. (1996). [Predictive mortality factors and the development of major complications in non-traumatic subarachnoid hemorrhage].. PubMed. 24(126). 193–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026